False negative rate and concordance of ThyGeNEXT®+ThyraMIR® testing with post-thyroidectomy histopathology
The low false-negative rate and positive concordance with histopathology highlights the utility of ThyGeNEXT® + ThyraMIR® in enhancing risk stratification and guiding personalized management of indeterminate thyroid nodules and thyroid cancer.
Authors
- Sheriff Mohammed
- Daniel Mettman (ORCID: https://orcid.org/0000-0003-1735-8925)
- Mariana Garcia‐Touza
- Betty M. Drees
- Maricel Ridella
Institutions
- Stowers Institute for Medical Research (US)
- Kansas City VA Medical Center (US)
- University of Missouri–Kansas City (US)
Publication Details
- Journal
- Journal of Clinical & Translational Endocrinology
- Published
- 2025-04-24
- DOI
- https://doi.org/10.1016/j.jcte.2025.100396
- Citations
- 1
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.29